Search results for: 'parc market share'

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as assay components for detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market o...

19 Aug 2022  |  North America  |  Market Research

Global Antibody Therapeutics Growth Opportunities

The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

Infographics

×

Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

13 Jan 2021  |  North America  |  Market Research

Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024

Customers’ Unmet Needs and New Technical Applications to Create Opportunities in the MRI Market

Infographics

×

This research service presents an analysis of the global magnetic imaging resonance (MRI) market. It is an in-depth analysis of the current trends, market size, revenue forecast, market penetration, market attractiveness, and low-end, mid-range, high-end Tesla MRI, and extremity MRI. The market is broken down into various regions also.--BEGIN PROMO...

23 Dec 2022  |  North America  |  Market Research

Growth Opportunities in the Vendor Neutral Archiving Solutions Industry

Large Imaging Data Silos and a Rising Number of Medical Imaging Procedures Drive the Demand for VNA

Infographics

×

This research provides an overview of the global vendor neutral archive (VNA) solutions industry, covering North America (NA), Europe, and Asia-Pacific (APAC). VNA solutions are defined as software, platform, and professional services that healthcare facilities extensively utilize to establish a repository of images and data from different picture ...

This research service studies the spinal surgery market in the United States. The market is segmented as total disc arthroplasty, vertebral compression fracture devices, nucleus replacement and spinal fusion markets. It covers the market from the aspects of the driving forces, restraints and challenges, also providing strategic recommendations. Rev...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

The laboratory information management systems (LIMS) industry in the United States and Europe is forecast to grow from 2023 to 2027 at a CAGR of 8.8% and 6.3%, respectively, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Prominent players in the US and EU LIMS industries, such as ThermoFis...

This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...